Handelsman DJ, et al. Androgen physiology, pharmacology, use and misuse. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext. South Dartmouth: MDText.com, Inc.; 2020. p. 5.

Google Scholar 

Yeap BB, Grossmann M, McLachlan RI, et al. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy. Med J Aust. 2016;205:173–8.

Article  PubMed  Google Scholar 

Yeap BB, Grossmann M, McLachlan RI, et al. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. Med J Aust. 2016;205:228–31.

Article  PubMed  Google Scholar 

Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715–44.

Article  PubMed  Google Scholar 

De Silva NL, Papanikolaou N, Grossmann M, et al. Male hypogonadism: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2024;12:761–74.

Article  PubMed  Google Scholar 

Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, Handelsman DJ. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab. 2005;90:5928–36.

Article  CAS  PubMed  Google Scholar 

Yeap BB, Alfonso H, Chubb SA, et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. J Clin Endocrinol Metab. 2012;97:4030–9.

Article  CAS  PubMed  Google Scholar 

Shi Z, Araujo AB, Martin S, O’Loughlin P, Wittert GA. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab. 2013;98:3289–97.

Article  CAS  PubMed  Google Scholar 

Camacho EM, Huhtaniemi IT, O’Neill TW, et al. Age-associated changes hypothalamic-pituitary-testicular function in middle-aged and older men modified by weight changes and lifestyle factors: longitudinal results from European Male Ageing Study. Eur J Endocrinol. 2013;168:445–55.

Article  CAS  PubMed  Google Scholar 

Marriott RJ, Murray K, Adams RJ, et al. Factors associated with circulating sex hormones in men: individual participant data meta-analyses. Ann Intern Med. 2023;176:1221–34.

Article  PubMed  PubMed Central  Google Scholar 

Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86:724–31.

Article  CAS  PubMed  Google Scholar 

Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87:589–98.

Article  CAS  PubMed  Google Scholar 

Handelsman DJ, Yeap BB, Flicker L, Martin S, Wittert GA, Ly LP. Age-specific population centiles for androgen status in men. Eur J Endocrinol. 2015;173:809–17.

Article  CAS  PubMed  Google Scholar 

Yeap BB, Manning L, Chubb SAP, et al. Progressive impairment of testicular endocrine function in ageing men: testosterone and dihydrotestosterone decrease, and luteinizing hormone increases, in men transitioning from the 8th to 9th decades of life. Clin Endocrinol (Oxf). 2018;88:88–95.

Article  CAS  PubMed  Google Scholar 

Cohen J, Nassau DE, Patel P, et al. Low testosterone in adolescents and young adults. Front Endocrinol. 2020;10:916.

Article  Google Scholar 

Hodges-Simeon CR, Grail GPO, Albert G, et al. Testosterone therapy masculinizes speech and gender presentation in transgender men. Sci Rep. 2021;11:3494.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu FCW, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123–35.

Article  CAS  PubMed  Google Scholar 

Travison TG, Vesper HW, Orwoll E, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102:1161–73.

Article  PubMed  PubMed Central  Google Scholar 

Handelsman DJ. Free testosterone: pumping up the tires or ending the free ride? Endocr Rev. 2017;38:297–301.

Article  PubMed  Google Scholar 

Nyamaah JA, Narinx N, Antonio L, Vanderschueren D. Use of calculated free testosterone in men: advantages and limitations. Curr Opin Endocrinol Diabetes Obes. 2024;31:230–5.

Article  CAS  PubMed  Google Scholar 

Jasuja R, Pencina KM, Spencer DJ, et al. Reference intervals for free testosterone in adult men measured using a standardized equilibrium dialysis procedure. Andrology. 2023;11:125–33.

Article  CAS  PubMed  Google Scholar 

Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf). 2010;73:382–8.

Article  CAS  PubMed  Google Scholar 

Yeap BB, Wu FCW. Clinical practice update on testosterone therapy for male hypogonadism: contrasting perspectives to optimise care. Clin Endocrinol (Oxf). 2019;90:56–65.

Article  CAS  PubMed  Google Scholar 

Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A reappraisal of testosterone’s binding in circulation: physiological and clinical implications. Endocr Rev. 2017;38:302–24.

Article  PubMed  PubMed Central  Google Scholar 

Narinx N, Marriott RJ, Murray K, et al. Sociodemographic, lifestyle and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses. Eur J Endocrinol. 2024;191:523–34.

Article  PubMed  Google Scholar 

Yeap BB, Marriott RJ, Antonio L, et al. Sociodemographic, lifestyle and medical influences on serum testosterone and sex hormone-binding globulin in men from UK Biobank. Clin Endocrinol (Oxf). 2021;94:290–302.

Article  CAS  PubMed  Google Scholar 

Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. 2011;96:2341–53.

Article  CAS  PubMed  Google Scholar 

Grossmann M. Indications for testosterone therapy in men. Curr Opin Endocrinol Diabetes Obes. 2024;31:249–56.

Article  CAS  PubMed  Google Scholar 

Yeap BB, Tran C, Douglass CM, McNeil JJ. Beyond T-Trials, T4DM and TRAVERSE: the next large testosterone randomized controlled trial. Curr Opin Endocrinol Diabetes Obes. 2024;31:222–9.

Article  CAS  PubMed  Google Scholar 

Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374:611–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Snyder PJ, Bhasin S, Cunningham GR, et al. Lessons from the testosterone trials. Endocr Rev. 2018;39:369–86.

Article  PubMed  PubMed Central  Google Scholar 

Wittert G, Atlantis E, Allan C, et al. Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): design and implementation of a double-blind randomised controlled trial. Diabetes Obes Metab. 2019;21:772–80.

Article  CAS  PubMed  Google Scholar 

Wittert G, Bracken K, Robledo KP, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle program (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9:32–45.